These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24363762)

  • 21. Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.
    Zhang T; Shen X; Liu R; Zhu G; Bishop J; Xing M
    Oncotarget; 2017 Jan; 8(1):900-914. PubMed ID: 27863429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.
    Zhao S; Wang Q; Li Z; Ma X; Wu L; Ji H; Qin G
    J Exp Clin Cancer Res; 2015 Dec; 34():146. PubMed ID: 26637328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis.
    He J; Jin Y; Zhou M; Li X; Chen W; Wang Y; Gu S; Cao Y; Chu C; Liu X; Zou Q
    Cancer Sci; 2018 Mar; 109(3):642-655. PubMed ID: 29274137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
    Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
    Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
    Fan C; Wang W; Jin J; Yu Z; Xin X
    Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
    Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
    Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional analysis of three novel cell lines derived from human papillary thyroid carcinomas with three different clinical courses.
    Ishikawa M; Tachibana T; Hashimoto H; Toyomura J; Ito T; Tsuboi K; Shibuya K; Hirose T; Minami S; Yoshino G
    Hum Cell; 2014 Jul; 27(3):111-20. PubMed ID: 24567186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
    Ye WC; Gao L; Huang J; Fang XM; Xie G
    Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
    Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
    FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of Foxp3 and TLR4 in human papillary thyroid carcinoma and its clinical significance.
    Xin J; Fu H; Zhang J; Zou H; Li Q; Yang W; Sun H
    Histol Histopathol; 2023 Mar; 38(3):339-347. PubMed ID: 36165427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC
    J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.
    Zhao Z; Herman JG; Brock MV; Sheng J; Zhang M; Liu B; Guo M
    PLoS One; 2014; 9(11):e112336. PubMed ID: 25375359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells.
    Xuqing W; Lei C; Zhengfa M; Shengchun D; Xin F; Jianguo Q; Jianxin Z
    Tumour Biol; 2012 Oct; 33(5):1419-27. PubMed ID: 22528941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aurora kinase A induces papillary thyroid cancer lymph node metastasis by promoting cofilin-1 activity.
    Maimaiti Y; Jie T; Jing Z; Changwen W; Pan Y; Chen C; Tao H
    Biochem Biophys Res Commun; 2016 Apr; 473(1):212-218. PubMed ID: 27003257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.
    Liao T; Qu N; Shi RL; Guo K; Ma B; Cao YM; Xiang J; Lu ZW; Zhu YX; Li DS; Ji QH
    Oncotarget; 2017 Jan; 8(1):238-247. PubMed ID: 27462868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beclin 1 is highly expressed in papillary thyroid carcinoma and correlates with lymph node metastasis.
    Li X; Xu H; Ma H
    Acta Chir Belg; 2013; 113(3):175-81. PubMed ID: 24941712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
    Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
    Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.